do you have to continue glp-1 forever Take Medications Forever? Doctors explain what really happens
Description
ArticlePubMed 141
bask.health Marketdata LLC $6.9 Billion Weight Loss Telehealth Market Analysis (Apr 16, 2024) Market size, growth projections, and patient spending data
Studies using exogenous GLP-1 infusion in humans demonstrated reduced energy intake, reduced appetite and decreased brain responses to food anticipation and consumption without direct changes in energy expenditure, and data strongly suggest that body-weight loss ensuing from GLP-1R agonist administration in humans largely reflects reductions in food intake [24, 25]
This widespread distribution suggests that GLP-1 receptor agonists like Ozempic may influence various aspects of brain function beyond glucose homeostasis

The thigh typically has more subcutaneous tissue than people realize, even in relatively lean individuals

Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus